Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03BAB
|
||||
| Former ID |
DNC008860
|
||||
| Drug Name |
Cacospongionolide E
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534672] | ||
| Formula |
C25H36O4
|
||||
| Canonical SMILES |
CC1CCC2(C(C1(C)CCC3=CCC(OC3)C4=CC(=O)OC4O)CCC=C2C)C
|
||||
| InChI |
1S/C25H36O4/c1-16-6-5-7-21-24(16,3)12-10-17(2)25(21,4)13-11-18-8-9-20(28-15-18)19-14-22(26)29-23(19)27/h6,8,14,17,20-21,23,27H,5,7,9-13,15H2,1-4H3/t17-,20+,21-,23+,24-,25-/m0/s1
|
||||
| InChIKey |
WBDQPITVPUAHAN-DRCQBYJMSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Phospholipase A2, membrane associated | Target Info | Inhibitor | [534672] | |
| Phospholipase A2 | Target Info | Inhibitor | [534672] | ||
| BioCyc Pathway | PhospholipasesLIPASYN-PWY:Phospholipases | ||||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Ether lipid metabolism | |||||
| Arachidonic acid metabolism | |||||
| Linoleic acid metabolism | |||||
| alpha-Linolenic acid metabolism | |||||
| Metabolic pathways | |||||
| Ras signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Pancreatic secretion | |||||
| Fat digestion and absorptionhsa00564:Glycerophospholipid metabolism | |||||
| Fat digestion and absorption | |||||
| Pathway Interaction Database | Glypican 1 networkfcer1pathway:Fc-epsilon receptor I signaling in mast cells | ||||
| References | |||||